151 related articles for article (PubMed ID: 36638349)
1.
Zhang R; Wang H; Xiao J; Lu J; Li M; Zhou Y; Sun H; Liu L; Huang T; Zhao Q
DNA Cell Biol; 2023 Jan; 42(1):27-42. PubMed ID: 36638349
[TBL] [Abstract][Full Text] [Related]
2. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer.
Chen Y; Huang X; Chen L; Weng G; Huang Z; Zhang Y; Xiao T; Chen J; Zhu K; Xu Y
Mol Biotechnol; 2023 Mar; 65(3):361-383. PubMed ID: 35780460
[TBL] [Abstract][Full Text] [Related]
4. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
Hu J; Yu A; Othmane B; Qiu D; Li H; Li C; Liu P; Ren W; Chen M; Gong G; Guo X; Zhang H; Chen J; Zu X
Theranostics; 2021; 11(7):3089-3108. PubMed ID: 33537076
[No Abstract] [Full Text] [Related]
5. Identification of enhancer RNA
Jia L; Chen J; Zhao J; Yang J
Transl Cancer Res; 2023 Dec; 12(12):3266-3283. PubMed ID: 38192978
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
7. Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients.
Yuan W; Yan J; Liu H; Li L; Wu B; Guo C; Zhang M
Pathol Oncol Res; 2021; 27():589662. PubMed ID: 34257539
[No Abstract] [Full Text] [Related]
8. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures.
Zhang Y; Zhu M; Mo J; Xian L
Aging (Albany NY); 2021 Dec; 13(24):26118-26136. PubMed ID: 34954689
[TBL] [Abstract][Full Text] [Related]
10. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y
BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the molecular profiling and tumor immune microenvironment of three subtypes of esophageal cancer.
Yu C; Xi Y; Zhang P; He N; Shen W
J Gene Med; 2023 May; 25(5):e3482. PubMed ID: 36786041
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study.
Vered M; Lehtonen M; Hotakainen L; Pirilä E; Teppo S; Nyberg P; Sormunen R; Zlotogorski-Hurvitz A; Salo T; Dayan D
BMC Cancer; 2015 Jan; 15():25. PubMed ID: 25633184
[TBL] [Abstract][Full Text] [Related]
13. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
Front Immunol; 2021; 12():691811. PubMed ID: 34489938
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer.
Mei PY; Xiao H; Guo Q; Meng WY; Wang ML; Huang QF; Liao YD
Oncol Lett; 2023 Feb; 25(2):68. PubMed ID: 36644145
[TBL] [Abstract][Full Text] [Related]
15. Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).
Cao R; Yuan L; Ma B; Wang G; Tian Y
Cancer Immunol Immunother; 2021 Jan; 70(1):1-18. PubMed ID: 32617668
[TBL] [Abstract][Full Text] [Related]
16. Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis.
Ye Y; Jiang H; Wu Y; Wang G; Huang Y; Sun W; Zhang M
Front Mol Biosci; 2022; 9():1001225. PubMed ID: 36213111
[No Abstract] [Full Text] [Related]
17. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.
Du H; Pang S; Li Y; Zhu L; Hang J; Chen L
J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327
[TBL] [Abstract][Full Text] [Related]
18. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
Liu Z; Tang Q; Qi T; Othmane B; Yang Z; Chen J; Hu J; Zu X
Front Immunol; 2021; 12():725223. PubMed ID: 34484235
[TBL] [Abstract][Full Text] [Related]
19. eIF6 is potential diagnostic and prognostic biomarker that associated with
Gao Y; Yuan L; Zeng J; Li F; Li X; Tan F; Liu X; Wan H; Kui X; Liu X; Ke C; Pei Z
J Transl Med; 2022 Jul; 20(1):303. PubMed ID: 35794622
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment.
Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
